Free Trial
NASDAQ:GDRX

GoodRx Q3 2026 Earnings Report

GoodRx logo
$3.25 -0.02 (-0.61%)
Closing price 04:00 PM Eastern
Extended Trading
$3.24 -0.02 (-0.46%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

GoodRx EPS Results

Actual EPS
N/A
Consensus EPS
$0.08
Beat/Miss
N/A
One Year Ago EPS
N/A

GoodRx Revenue Results

Actual Revenue
N/A
Expected Revenue
$202.12 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

GoodRx Announcement Details

Quarter
Q3 2026
Time
After Market Closes
Conference Call Date
Wednesday, November 4, 2026
Conference Call Time
8:00AM ET

Conference Call Resources

GoodRx Earnings Headlines

3 reasons to avoid GDRX and 1 stock to buy instead
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.tc pixel
See More GoodRx Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like GoodRx? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GoodRx and other key companies, straight to your email.

About GoodRx

GoodRx (NASDAQ:GDRX) operates a healthcare technology platform that helps consumers find prescription medications at lower prices. Through its website and mobile applications, GoodRx allows users to compare prescription prices at participating pharmacies, access discount coupons and identify potential savings on commonly prescribed medications. The company’s services are primarily focused on the United States.

GoodRx also offers GoodRx Gold, a membership program that provides additional discounts on eligible prescriptions, as well as telehealth services that connect consumers with healthcare providers for certain medical consultations and prescriptions. Its platform may also provide medication information, price comparisons and tools intended to support healthcare decision-making.

In addition to its consumer offerings, GoodRx works with healthcare providers and pharmaceutical manufacturers through services designed to improve prescription access, affordability and patient engagement. The company was founded in 2011 by Trevor Bezdek, Doug Hirsch and Scott Marlette and became a publicly traded company on the Nasdaq under the symbol GDRX in 2020.

View GoodRx Profile